This article reviews animal models currently used for investigation of ascending genital-tract infection in pregnancy. The specific models reviewed are those in the rabbit, monkey, and mouse. These models investigate both the direct effects of bacteria in the setting of ascending infection and the role of cytokines produced by the immune system. For each model, experiments that delineate the pathophysiology of ascending genital-tract infection in pregnancy are described. Intervention experiments, including the use of antibiotics, anti-inflammatory agents, immunotherapy, and anti-cytokine therapy, are described. Comparison of these models is made with respect to pathogenesis in humans, reproducibility, anatomy, and cost. (C) We also sought to determine whether intervention could improve the outcome of fulminant intraamniotic infection and sepsis and fetal death which occurred uniformly after intrauterine inoculation. First, we studied the effect of antibiotic intervention after intrauterine inoculation with E. coli. Rabbits on day 21 or 22 were inoculated hysteroscopically with 0.2 ml of E. coli (105 cfu/ml). Animals received either no treatment or ampicillin/ sulbactam, 100 mg/kg/day IM, in 3-4 divided doses, beginning 1-2 h before bacterial inoculation and continuing up to 7 days. An additional series of animals was inoculated with E. coli and treated with ampicillin/sulbactam immediately after inoculation (0 h, 2 h, or 4 h after inoculation). In this series, the dosage was increased to 150 mg/kg/day when serum ampicillin/sulbactam levels in the initial animals showed values in the low therapeutic range.
Animal models in which variables can be controlled allow the hypotheses generated from human cases to be tested in the laboratory.
The purpose of this article is to review the current animal models of ascending infection in pregnancy. These models investigate the direct effects of bacteria in the setting of ascending infection, as well as the role of cytokines which are produced by the immune system. Particular emphasis will be given to the rabbit, monkey, and mouse models under current investigation.
RABBIT MODEL
The rabbit has long been a model for bacterial infection. Advantages to this species have included not only its excellent response to microbiologic challenge, but also its size and ease of manipulation. Because of these latter attributes, direct bacterial challenge to the genital tract has been possible using a hysteroscope.
The rabbit is in a continuous state of estrus.
Pregnancy can be achieved readily through natural means or through artificial insemination and ovulation induction by human chorionic gonadotropin. The gestational length is 30-31 days. The rabbit has 2 cervices and 2 uterine horns, similar to the human uterus didelphys. A thin vaginal septum separates the cervices. The average litter size is 7-8 pups.
Experimental Model Timed pregnant New Zealand white rabbits are anesthetized with xylazine hydrochloride (5 mg/ kg) and ketamine hydrochloride (20-25 mg/kg).
After perineal and lower vaginal preparation of the rabbit with povidone-iodine, a hysteroscope (Storz 27020B, Karl Storz Endoscopy-America, Inc., Culver City, CA) is introduced vaginally and advanced. The inoculum is delivered through the operating port of the hysteroscope via a sterile polyethylene cannula (0.15 cm in outer diameter) which is prefilled and attached to a tuberculin syringe. The bacterial inoculum may be placed in the uterus (Fig. 1 ), the cervix (Fig. 2) In our laboratory, 3 we have confirmed the findings of Dombroski et 
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The natural history of this model after intracervical inoculation with E. coli was described by McDuf- fie et al. 6 The primary objective of this study was to determine whether cytokines were produced in the AF after intracervical inoculation with E. coli. Timed pregnant rabbits on day 21 As in intraamniotic infection in humans, levels of prostaglandins and cytokines are elevated after bacterial infection. This is confirmed in both the rabbit and monkey models. Because of technical considerations, it is necessary to pool AF in the rabbit model in order to obtain enough for several assays. In the monkey, there is a greater amount of AF present. This potentially could be harvested by both repeated aminocenteses or chronic catheterization, as done by Gravett et al. 10 The advantage of this latter technique allows for serial sampling within a given individual. It is more difficult in small animals to achieve the technology necessary to sample serially.
Clearly, the underlying physiology favors the monkey model because of its comparability to humans. Both uterine anatomy and litter size are markedly different for both the rabbit and the mouse. In addition, maternal pharmacokinetics and the pharmacokinetics of placental transfer may be markedly different from species to species. The cost factor obviously favors a less-expensive model with a shorter gestation, as in the rabbit and mouse models. Nevertheless, the work in the monkey is critical to the validity of other work obtained from less-costly models.
In this review, we have discussed the current animal models of ascending infection in pregnancy. The primary advantages of the rabbit model are its
